The Medicines Patent Pool Foundation (MPP)’s five-year strategic plan supports its mission of increasing access to, and facilitating the development of, life-saving medicines for low- and middle-income countries. The new strategy calls for renewed efforts to provide better treatment options for people living with HIV, hepatitis C and tuberculosis. Based on the findings of a feasibility study, the plan also recommends the expansion of the MPP model to patented medicines with high medical value, starting with small molecules on the World Health Organization Model List of Essential Medicines (EML).

We thank Unitaid for its confidence and continued financial support.

This website uses cookies to ensure you get the best experience on our website. Learn More